Two-week course of sleep aid increases CPAP adherence in OSA patients at six months
Monday, May 18, 2009 - 12:35
in Health & Medicine
New research suggests that patients newly diagnosed with obstructive sleep apnea (OSA) who use a short-course of the sleep aid, eszopiclone, when beginning continuous positive airway pressure (CPAP) therapy, are more adherent with therapy in six months.